Canadian Stroke Consortium (CSC) Report issue

Academic/Hospital Phase 3

Organization Overview

First Clinical Trial
2003
NCT00109382
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

Canadian Stroke Consortium (CSC)